“…Other reports also demonstrated that some of these constituents (sesamol, sesamolin, sesamin, and sesaminol) inhibit the proinflammatory cytokines such as TNF‐α, IL‐1β, IL‐6, and NF‐kB either in vivo rat (Bournival, Plouffe, Renaud, Provencher, & Martinoli, ; Chen et al, ; Hemshekhar et al, ; Hsu, Chu, Chandrasekaran, & Liu, ; Jeng & Hou, ; Yashaswini et al, 2017b) or in vitro cell culture model (Bournival et al, ). Sesamol, sesamolin, and sesamin also suppress the inflammatory cascade by downregulating the expression of caspase‐3 (Baluchnejadmojarad, Mansouri, Ghalami, Mokhtari, & Roghani, ; Chopra, Tiwari, Arora, & Kuhad, ; Hsieh et al, ; Hung et al, ; Jeng & Hou, ). A recent clinical trial was reported on sesamin supplementation on cardiovascular risk factors in women with rheumatoid arthritis, and the results found that sesamin research had been conducted and evaluated by Helli, Mowla, Mohammadshahi, and Jalali (), which showed protective effect of SO (Helli et al, ).…”